Reply to “Response to “CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype”. Haematologica...

Por Paíno, Teresa, Paiva, Bruno, San Miguel, Jesús F.
Publicado em 2013

Biological Background of Resistance to Current Standards of Care in Multiple Myeloma

Por Mogollón, Pedro, Díaz-Tejedor, Andrea, Algarín, Esperanza M., Paíno, Teresa, Garayoa, Mercedes, Ocio, Enrique M.
Publicado no Cells (2019)

Immune System Alterations in Multiple Myeloma: Molecular Mechanisms and Therapeutic Strategies to Reverse Immunosuppression

Por Díaz-Tejedor, Andrea, Lorenzo-Mohamed, Mauro, Puig, Noemí, García-Sanz, Ramón, Mateos, María-Victoria, Garayoa, Mercedes, Paíno, Teresa
Publicado no Cancers (Basel) (2021)

CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype

Por Paíno, Teresa, Ocio, Enrique M., Paiva, Bruno, San-Segundo, Laura, Garayoa, Mercedes, Gutiérrez, Norma C., Sarasquete, M. Eugenia, Pandiella, Atanasio, Orfao, Alberto, San Miguel, Jesús F.
Publicado em 2012

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

Por Misiewicz-Krzeminska, Irena, Sarasquete, María E., Quwaider, Dalia, Krzeminski, Patryk, Ticona, Fany V., Paíno, Teresa, Delgado, Manuel, Aires, Andreia, Ocio, Enrique M., García-Sanz, Ramón, San Miguel, Jesús F., Gutiérrez, Norma C.
Publicado em 2013

Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines

Por Paíno, Teresa, Sarasquete, María E., Paiva, Bruno, Krzeminski, Patryk, San-Segundo, Laura, Corchete, Luis A., Redondo, Alba, Garayoa, Mercedes, García-Sanz, Ramón, Gutiérrez, Norma C., Ocio, Enrique M., San-Miguel, Jesús F.
Publicado em 2014

Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma

Por Paíno, Teresa, González-Méndez, Lorena, San-Segundo, Laura, Corchete, Luis A., Hernández-García, Susana, Díaz-Tejedor, Andrea, Algarín, Esperanza M., Mogollón, Pedro, Martín-Sánchez, Montserrat, Gutiérrez, Norma C., Mateos, María-Victoria, Garayoa, Mercedes, Ocio, Enrique M.
Publicado no Cancers (Basel) (2020)

Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone

Por López-Iglesias, Ana-Alicia, González-Méndez, Lorena, San-Segundo, Laura, Herrero, Ana B., Hernández-García, Susana, Martín-Sánchez, Montserrat, Gutiérrez, Norma C., Paíno, Teresa, Avilés, Pablo, Mateos, María-Victoria, San-Miguel, Jesús F., Garayoa, Mercedes, Ocio, Enrique M.
Publicado no Haematologica (2017)

Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma

Por Algarín, Esperanza M., Quwaider, Dalia, Campos-Laborie, Francisco J., Díaz-Tejedor, Andrea, Mogollón, Pedro, Vuelta, Elena, Martín-Sánchez, Montserrat, San-Segundo, Laura, González-Méndez, Lorena, Gutiérrez, Norma C., García-Sanz, Ramón, Paíno, Teresa, De Las Rivas, Javier, Ocio, Enrique M., Garayoa, Mercedes
Publicado no Cells (2021)

Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response

Por Colado, Enrique, Paíno, Teresa, Maiso, Patricia, Ocio, Enrique M., Chen, Xi, Álvarez-Fernández, Stela, Gutiérrez, Norma C., Martín-Sánchez, Jesús, Flores-Montero, Juan, San Segundo, Laura, Garayoa, Mercedes, Fernández-Lázaro, Diego, Vidriales, Maria-Belen, Galmarini, Carlos M., Avilés, Pablo, Cuevas, Carmen, Pandiella, Atanasio, San-Miguel, Jesús F.
Publicado em 2011

The kinesin spindle protein inhibitor filanesib enhances the activity of pomalidomide and dexamethasone in multiple myeloma

Por Hernández-García, Susana, San-Segundo, Laura, González-Méndez, Lorena, Corchete, Luis A., Misiewicz-Krzeminska, Irena, Martín-Sánchez, Montserrat, López-Iglesias, Ana-Alicia, Algarín, Esperanza Macarena, Mogollón, Pedro, Díaz-Tejedor, Andrea, Paíno, Teresa, Tunquist, Brian, Mateos, María-Victoria, Gutiérrez, Norma C, Díaz-Rodriguez, Elena, Garayoa, Mercedes, Ocio, Enrique M
Publicado no Haematologica (2017)

Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

Por Algarín, Esperanza M, Díaz-Tejedor, Andrea, Mogollón, Pedro, Hernández-García, Susana, Corchete, Luis A., San-Segundo, Laura, Martín-Sánchez, Montserrat, González-Méndez, Lorena, Schoumacher, Marie, Banquet, Sebastien, Kraus-Berthier, Laurence, Kloos, Ioana, Derreal, Alix, Halilovic, Ensar, Maacke, Heiko, Gutiérrez, Norma C., Mateos, María-Victoria, Paíno, Teresa, Garayoa, Mercedes, Ocio, Enrique M.
Publicado no Haematologica (2020)

Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

Por López-Iglesias, Ana-Alicia, Herrero, Ana B., Chesi, Marta, San-Segundo, Laura, González-Méndez, Lorena, Hernández-García, Susana, Misiewicz-Krzeminska, Irena, Quwaider, Dalia, Martín-Sánchez, Montserrat, Primo, Daniel, Paíno, Teresa, Bergsagel, P. Leif, Mehrling, Thomas, González-Díaz, Marcos, San-Miguel, Jesús F., Mateos, María-Victoria, Gutiérrez, Norma C., Garayoa, Mercedes, Ocio, Enrique M.
Publicado no J Hematol Oncol (2017)

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial

Por Puig, Noemí, Corchete-Sánchez, Luis A., Pérez-Morán, José J., Dávila, Julio, Paíno, Teresa, de la Rubia, Javier, Oriol, Albert, Martín-Sánchez, Jesús, de Arriba, Felipe, Bladé, Joan, Blanchard, María-Jesús, González-Calle, Verónica, García-Sanz, Ramón, Paiva, Bruno, Lahuerta, Juan-José, San-Miguel, Jesús F., Mateos, María-Victoria, Ocio, Enrique M.
Publicado no Cancers (Basel) (2020)